The decision to review the company's application comes shortly after the earlier rejection sparked major controversy.
WASHINGTON — The Food and Drug Administration reversed course and told Moderna it would review its application for a new flu vaccine, the company announced Wednesday.
The agency told Moderna earlier this month that it would not review the submission ... [623 chars]